TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33650089

Group type: EXPERIMENTAL
Intervention: TEAS combined with dexamethasone and tropisetron
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (dexamethasone and tropisetron)
Number of subjects: 62
Study: 33127971

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment in PCOS patients (PCOS-T)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (PCOS-C)
Number of subjects: 109
Study: 616850902

Group type: EXPERIMENTAL
Intervention: Breakfast Skipping Day (BSD)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dinner Skipping Day (DSD)
Number of subjects: 17

Group type: COMPARATOR
Intervention: 3-meal control
Number of subjects: 17
Study: 35681255

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation initiated prior to conception (arm 1)
Number of subjects: 2337

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation initiated in early pregnancy (arm 2)
Number of subjects: 2337

Group type: COMPARATOR
Intervention: Control arm (arm 3)
Number of subjects: 2337
Study: 34222163

Group type: EXPERIMENTAL
Intervention: Expressive writing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 36254858

Group type: EXPERIMENTAL
Intervention: Family care following early deprivation
Number of subjects: 143

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 143
Study: 34211004

Group type: EXPERIMENTAL
Intervention: Original communication calls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Increased spectro-temporal distortion in communication calls
Number of subjects: 0
Study: 35525262

Group type: EXPERIMENTAL
Intervention: Early invasive strategy group (primary percutaneous coronary intervention, PPCI)
Number of subjects: 366

Group type: COMPARATOR
Intervention: Conservative strategy group (optimal medical therapy with primary PCI not performed)
Number of subjects: 366
Study: 34319944

Group type: EXPERIMENTAL
Intervention: II + ID resistance training (RT)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: DD resistance training (RT)
Number of subjects: 320

Group type: COMPARATOR
Intervention: II + ID control (CTL)
Number of subjects: 320

Group type: COMPARATOR
Intervention: DD control (CTL)
Number of subjects: 320
Study: 34000907

Group type: EXPERIMENTAL
Intervention: Crisis/Broken stories
Number of subjects: 4497

Group type: EXPERIMENTAL
Intervention: Counterfeit stories
Number of subjects: 4497

Group type: EXPERIMENTAL
Intervention: Problem explored stories
Number of subjects: 4497

Group type: EXPERIMENTAL
Intervention: Problem-focused stories
Number of subjects: 4497

Group type: COMPARATOR
Intervention: All stories
Number of subjects: 4497
Study: 35067819

Group type: EXPERIMENTAL
Intervention: Individualized management program comprising a tailored chronic disease management plan and education
Number of subjects: 563

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 563
Study: 33806089

Group type: EXPERIMENTAL
Intervention: Cervical deep muscle flexion exercises for 4 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Stretching exercises for 4 weeks
Number of subjects: 32
Study: 33141187

Group type: EXPERIMENTAL
Intervention: Maternal blood lead levels (BLLs)
Number of subjects: 20000
Study: 35734811

Group type: EXPERIMENTAL
Intervention: Telenursing intervention (telephone calls twice a week for the first six weeks, then once a week until week 12)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Telenursing intervention
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (no telenursing intervention)
Number of subjects: 95
Study: 32506124

Group type: EXPERIMENTAL
Intervention: Cohesive polydensified matrix hyaluronic acid filler (CPM-HA)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Small-particle hyaluronic acid filler with 0.3% lidocaine (SP-HAL)
Number of subjects: 48
Study: 32699167

Group type: EXPERIMENTAL
Intervention: Remote monitoring strategy using wearable biosensors
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard strategy (control group)
Number of subjects: 200
Study: 32568788

Group type: EXPERIMENTAL
Intervention: Chest ultrasound
Number of subjects: 89

Group type: COMPARATOR
Intervention: Routine diagnostic approach
Number of subjects: 89
Study: 34280944

Group type: EXPERIMENTAL
Intervention: Room temperature contrast material (23°C)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Prewarmed contrast material (37°C)
Number of subjects: 218
Study: 33625387

Group type: EXPERIMENTAL
Intervention: Anatomical teeth (AT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonanatomical teeth (NT)
Number of subjects: 50
Study: 32427553

Group type: EXPERIMENTAL
Intervention: 635 nm diode laser (8‐mm diameter handpiece in contact mode, delivering 8 J/cm2 over a period of 20 sec applied over sensitive points)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (same protocol without laser activation)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 635 nm diode laser
Number of subjects: 42
Study: 35994200

Group type: EXPERIMENTAL
Intervention: Ozanimod (Zeposia®)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33595879

Group type: EXPERIMENTAL
Intervention: Early on-demand (EOD) drainage
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 30
Study: 33256694

Group type: EXPERIMENTAL
Intervention: Specific sensorimotor treatment (SMT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: General exercise (GE)
Number of subjects: 34
Study: 33820711

Group type: EXPERIMENTAL
Intervention: Repetitive facilitative exercise (RFE) and botulinum toxin type A (BoNT‐A) injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Repetitive facilitative exercise (RFE) only
Number of subjects: 40
Study: 34678892

Group type: EXPERIMENTAL
Intervention: Modified Chong-Chet technique
Number of subjects: 129

Group type: COMPARATOR
Intervention: Standard Chong-Chet technique
Number of subjects: 129
Study: 32883231

Group type: EXPERIMENTAL
Intervention: EST‐SSR markers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Population genetic analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Migration rate analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian structure analysis
Number of subjects: 0
Study: 35089106

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 34603972

Group type: EXPERIMENTAL
Intervention: Patient-driven iCBT
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard iCBT
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 55
Study: 35232469

Group type: EXPERIMENTAL
Intervention: Home visiting, iron supplementation, Participatory Learning and Action (PLA) groups, plus routine antenatal care (ANC)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Routine antenatal care (ANC)
Number of subjects: 842
Study: 35491401

Group type: EXPERIMENTAL
Intervention: Biomarker-guided therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care therapy
Number of subjects: 0
Study: 33925171

Group type: EXPERIMENTAL
Intervention: SEMS positioning (Group 1, 13 patients)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Open stomach-partitioning gastrojejunostomy (Group 2, 14 patients)
Number of subjects: 27
Study: 35473432

Group type: EXPERIMENTAL
Intervention: Mindfulness induction
Number of subjects: 164

Group type: COMPARATOR
Intervention: Active control task
Number of subjects: 164
Study: 34650303

Group type: EXPERIMENTAL
Intervention: Nocardia rubra cell wall skeleton (Nr‐CWS) combined with normal saline
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical placebo without Nr‐CWS combined with normal saline
Number of subjects: 60
Study: 32709784

Group type: EXPERIMENTAL
Intervention: Unimanual eyelid retraction
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Cotton-tipped applicator (CTA)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Speculum
Number of subjects: 99
Study: 35802640

Group type: EXPERIMENTAL
Intervention: Installation of nearshore, moored fish aggregating devices (FADs) to improve catch rates with existing fishing gears.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social and behaviour change (SBC) activity to promote fish consumption.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatments (FADs and SBC activities).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neither treatment (control group).
Number of subjects: 0
Study: 34050932

Group type: EXPERIMENTAL
Intervention: FIASMA medication
Number of subjects: 2846

Group type: COMPARATOR
Intervention: No FIASMA medication
Number of subjects: 2846
Study: 32079835

Group type: EXPERIMENTAL
Intervention: Cosmetic tattoos (colors yellow and green)
Number of subjects: 369

Group type: COMPARATOR
Intervention: No cosmetic tattoos (control group)
Number of subjects: 369
Study: 35314185

Group type: EXPERIMENTAL
Intervention: Multimodal experimental group (MMG)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard of care control (SOC)
Number of subjects: 47
Study: 32790036

Group type: EXPERIMENTAL
Intervention: Gaze-contingent music reward therapy (8 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition (gaze-noncontingent music, 8 sessions)
Number of subjects: 60
Study: 35294545

Group type: EXPERIMENTAL
Intervention: Bevacizumab added to temozolomide treatment
Number of subjects: 122

Group type: COMPARATOR
Intervention: Temozolomide treatment alone (control)
Number of subjects: 122
Study: 33952549

Group type: EXPERIMENTAL
Intervention: Complex intervention to share knowledge with teachers about CVI.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention implementation and knowledge of CVI.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes to visual clutter in classrooms.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes to school special educational needs and disability (SEND) policies.
Number of subjects: 0
Study: 35861630

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg once daily for 104 weeks
Number of subjects: 308

Group type: COMPARATOR
Intervention: Placebo once daily for 104 weeks
Number of subjects: 308
Study: 33714843

Group type: EXPERIMENTAL
Intervention: Sphincter preserving operation (SPO)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Abdominoperineal resection (APR)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Depth of tumor invasion
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Radial margin status
Number of subjects: 76
Study: 32402702

Group type: EXPERIMENTAL
Intervention: Routine noninvasive stress testing (exercise electrocardiography, nuclear stress imaging, or stress echocardiography) at 12 months post-PCI
Number of subjects: 1700

Group type: COMPARATOR
Intervention: Standard-care without routine testing
Number of subjects: 1700
Study: 35072852

Group type: EXPERIMENTAL
Intervention: 12-month capecitabine regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6-month regimen
Number of subjects: 0
Study: 34880344

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) using an Oculus Quest® helmet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Topical Anesthesia (TA) 20% benzocaine
Number of subjects: 21
Study: 35842736

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32928582

Group type: EXPERIMENTAL
Intervention: High-fat, predominantly dairy-based breakfast meal
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: High-fat, predominantly soy-based breakfast meal
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (non-MetS)
Number of subjects: 19
Study: 32826737

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 431
Study: 35461239

Group type: EXPERIMENTAL
Intervention: Laughter program (12-week duration)
Number of subjects: 235
Study: 33693546

Group type: EXPERIMENTAL
Intervention: Omixer - a Bioconductor package for sample randomization in omics studies
Number of subjects: 0
Study: 32247654

Group type: EXPERIMENTAL
Intervention: ErgoActive group (n=15) received 8 weeks of training with leap motion controller‐based virtual reality games, 1 day per week for 30min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n=15)
Number of subjects: 30
Study: 32978622

Group type: EXPERIMENTAL
Intervention: Proposed bivariate effect modification analysis method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing methods for bivariate effect modification analysis
Number of subjects: 0
Study: 33933732

Group type: EXPERIMENTAL
Intervention: Enteral formula including 4 proteins (P4)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Casein-dominant formula (Cas)
Number of subjects: 20
Study: 32607949

Group type: EXPERIMENTAL
Intervention: Iguratimod
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 50
Study: 34990777

Group type: EXPERIMENTAL
Intervention: 64Gy salvage RT
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: 70Gy salvage RT
Number of subjects: 344

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 344
Study: 32942255

Group type: EXPERIMENTAL
Intervention: Single-Stroke Kayak Test (SSKT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bench Press
Number of subjects: 21

Group type: COMPARATOR
Intervention: Prone Bench Pull
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: F-V slope
Number of subjects: 21
Study: 35606238

Group type: EXPERIMENTAL
Intervention: Endorsement of the vaccine from the pictured doctor (Poster M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endorsement with information about COVID-19 risk (Poster M + R)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endorsement with information about risk and appeal to get vaccinated to protect friends and family (Poster M + R + F)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control message (Control Poster)
Number of subjects: 0
Study: 34264698

Group type: EXPERIMENTAL
Intervention: PSYCHOPATHY.COMP program
Number of subjects: 119

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 119
Study: 35506965

Group type: EXPERIMENTAL
Intervention: Bulk fill resin composite (Filtek Bulk Fill Posterior Restorative)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Resin‐modified glass‐ionomer cement (Vitremer)
Number of subjects: 62
Study: 32442634

Group type: EXPERIMENTAL
Intervention: Four-plate fixation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Two-plate fixation
Number of subjects: 39
Study: 33618991

Group type: EXPERIMENTAL
Intervention: Hydro-jet dissection
Number of subjects: 68

Group type: COMPARATOR
Intervention: Ultrasonic surgical aspirator
Number of subjects: 68
Study: 35723127

Group type: EXPERIMENTAL
Intervention: Video-guided deep breathing (DB) integrated into conventional physiotherapy (CP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CP)
Number of subjects: 30
Study: 33427091

Group type: EXPERIMENTAL
Intervention: Category 1 anti-tubercular treatment with additional prednisolone
Number of subjects: 54

Group type: COMPARATOR
Intervention: Conventional anti-tubercular treatment alone (Control)
Number of subjects: 54
Study: 35254246

Group type: EXPERIMENTAL
Intervention: Specialist model (behavioral health counselor‐delivered brief intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generalist model (primary care provider‐delivered brief intervention)
Number of subjects: 0
Study: 34112063

Group type: EXPERIMENTAL
Intervention: Emotion Regulation Therapy for ICs (ERT‐C)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Homework completion
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Decentering
Number of subjects: 65
Study: 32832985

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention ('Step by Step')
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group (standard geriatric inpatient rehabilitation)
Number of subjects: 115
Study: 35647184

Group type: EXPERIMENTAL
Intervention: High Power Laser Therapy (HPLT) for 3 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional physiotherapy program (ultrasound therapy, moist heat pack, and home exercises) for 3 weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Comparison of HPLT vs Conventional physiotherapy
Number of subjects: 36
Study: 34153870

Group type: EXPERIMENTAL
Intervention: Deep learning model for detecting early-stage ONFH lesions on MRI
Number of subjects: 110
Study: 32791321

Group type: EXPERIMENTAL
Intervention: Expressive writing (alcohol vs. distress, guilt vs. no guilt)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control writing
Number of subjects: 600

Group type: COMPARATOR
Intervention: Personalized feedback
Number of subjects: 600
Study: 34697254

Group type: EXPERIMENTAL
Intervention: PLAYFun Program (12-week games-based program delivered by exercise physiologists)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Usual preschool curriculum (control group)
Number of subjects: 50
Study: 34248142

Group type: EXPERIMENTAL
Intervention: Local irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recombinant cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutralizing antibodies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Small-molecule inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DC vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oncolytic viruses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TLR agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SPM (specialized proresolving mediators)
Number of subjects: 0
Study: 32517674

Group type: EXPERIMENTAL
Intervention: Prevail Staff intervention (stigma reduction and psychoeducation about low intensity psychological interventions)
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Prevail Managers programme (communication skills, problem formulation, and problem-solving skills)
Number of subjects: 960

Group type: COMPARATOR
Intervention: Control (employment as usual)
Number of subjects: 960
Study: 35470483

Group type: EXPERIMENTAL
Intervention: Chlormethine gel
Number of subjects: 58
Study: 32286233

Group type: EXPERIMENTAL
Intervention: Competency-Based Learning and Assessment System (CBLAS)
Number of subjects: 117
Study: 34509404

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 590

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 590
Study: 34375135

Group type: EXPERIMENTAL
Intervention: Prolonged targeted temperature management (TTM) for 48 hours
Number of subjects: 114

Group type: COMPARATOR
Intervention: Standard targeted temperature management (TTM) for 24 hours
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Prolonged TTM (48 hours)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: MR-proANP and NT-proBNP levels at 24 hours
Number of subjects: 114
Study: 33933848

Group type: EXPERIMENTAL
Intervention: Silymarin (SM) plus Interferon beta (IFN‐β)
Number of subjects: 0
Study: 35844038

Group type: EXPERIMENTAL
Intervention: Telitacicept 80 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Telitacicept 160 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Telitacicept 240 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Telitacicept (all doses)
Number of subjects: 36
Study: 32881723

Group type: EXPERIMENTAL
Intervention: Two-talker speech masker
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Speech-shaped noise masker
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 2
Study: 35503342

Group type: EXPERIMENTAL
Intervention: Decompressive laminectomy
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Lumbar fusion
Number of subjects: 94

Group type: COMPARATOR
Intervention: Lumbar decompression alone
Number of subjects: 94

Group type: COMPARATOR
Intervention: Decompression plus fusion
Number of subjects: 94
Study: 36482603

Group type: EXPERIMENTAL
Intervention: Cycling exercise program combined with a cognitive task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34377197

Group type: EXPERIMENTAL
Intervention: Dexamethasone and dexmedetomidine combination
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 162
Study: 32812388

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.25 mg/kg diluted to 5 ml with 0.9% saline)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Placebo (5 ml of 0.9% saline)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (0.25 mg/kg)
Number of subjects: 330
Study: 34252374

Group type: COMPARATOR
Intervention: Adjuvant CapOx (intravenous oxaliplatin 130 mg/m2 on day one of each 21 day cycle plus oral capecitabine 1000 mg/m2 twice a day)
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Adjuvant SOX (intravenous oxaliplatin 130 mg/m2 on day one of each 21 day cycle plus oral S-1 40-60 mg twice a day)
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Perioperative SOX (intravenous oxaliplatin 130 mg/m2 on day one of each 21 day cycle plus oral S-1 40-60 mg twice a day for three cycles preoperatively and five cycles postoperatively followed by three cycles of S-1 monotherapy)
Number of subjects: 1022
Study: 34119628

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group without statin treatment
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Stable angina (SA)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Acute coronary syndrome (ACS)
Number of subjects: 105
Study: 34365900

Group type: EXPERIMENTAL
Intervention: FFP2/N95 face mask
Number of subjects: 0
Study: 33751401

Group type: EXPERIMENTAL
Intervention: IBI301 plus CHOP (375 mg/m2)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Rituximab plus CHOP (375 mg/m2)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: IBI301 plus CHOP
Number of subjects: 419

Group type: COMPARATOR
Intervention: Rituximab plus CHOP
Number of subjects: 419
Study: 33064780

Group type: EXPERIMENTAL
Intervention: Proportion of days alcohol abstinent
Number of subjects: 313
Study: 34708255

Group type: EXPERIMENTAL
Intervention: 50 μg lysergic acid diethylamide (LSD)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Inactive placebo
Number of subjects: 24
Study: 34782842

Group type: EXPERIMENTAL
Intervention: Family Empowerment Model
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80